Oestrogen therapy

Cholelithiasis - Oestrogen therapy Factor

Last reviewed for CCPS 28 May 2008.

Preliminary questions [6937]

7625 there is some evidence that oestrogen therapy may be a factor in the development of the condition under consideration.

224 the veteran has had oestrogen treatment.

6940 — the veteran has established the causal connection between the course of treatment with oestrogen therapy and VEA service for the clinical onset of cholelithiasis.

6941 — the veteran has established the causal connection between the course of treatment with oestrogen therapy and operational service for the clinical onset of cholelithiasis.

or

6942 — the veteran has established the causal connection between the course of treatment with oestrogen therapy and eligible service for the clinical onset of cholelithiasis.

Clinical onset and operational service [6941]

6943 the veteran had oestrogen therapy as specified in the reasonable hypothesis Statement of Principles for cholelithiasis.

6944

operational service made a material contribution to oestrogen therapy as specified in the reasonable hypothesis Statement of Principles for cholelithiasis.

6945

the oestrogen therapy as specified in the reasonable hypothesis Statement of Principles for cholelithiasis, which was caused by operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [6942]

6946

the veteran had oestrogen therapy as specified in the balance of probabilities Statement of Principles for cholelithiasis.

6947

eligible service made a material contribution to oestrogen therapy as specified in the balance of probabilities Statement of Principles for cholelithiasis.

6948

the oestrogen therapy as specified in the balance of probabilities Statement of Principles for cholelithiasis, which was caused by eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.